News

disease_




03/30/2009	BioAdvance Greenhouse Announces Seed-Stage Investment in Novira Therapeutics to Advance Antiviral Drug Discovery
03/30/2009	BARC Central Laboratory Joins Alzheimer's Association Research Roundtable
03/03/2008	Canadian to Lead American Association of Geriatric Psychiatry
04/27/2006	Transition Therapeutics Receives Clearance to Initiate Phase I Clinical Trial with Alzheimer's Disease Product AZD-103
05/12/2005	Spirituality, religious practice may slow Alzheimer's
05/06/2005	Myriad Genetics reports results of Phase II trial of Flurizan in patients with Alzheimer's disease.
05/01/2005	Therapy slows dementia
04/29/2005	Ceregene scientific co-founder publishes Alzheimer's disease clinical trial results in nature medicine.
04/26/2005	Allon Therapeutics selected by the Alzheimer's Disease Cooperative Study
02/09/2005	Vasogen initiates Phase I clinical trial of VP025.
[ 1 \| 2 \| 3 \| 4]

Brought to you under the editorial guidance or our European Advisory Board